ORMP
NASDAQ · Pharmaceuticals
Oramed Pharmaceuticals Inc
$4.50
+0.04 (+0.90%)
Open$4.48
Previous Close$4.46
Day High$4.53
Day Low$4.43
52W High$5.19
52W Low$1.98
Volume—
Avg Volume168.5K
Market Cap178.87M
P/E Ratio1.63
EPS$2.59
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+112.2% upside
Current
$4.50
$4.50
Target
$9.55
$9.55
$5.95
$9.55 avg
$10.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.31M | 2.02M | 32.28M |
| Net Income | 60.02M | 58.29M | 5.51M |
| Profit Margin | 412.3% | 3,042.4% | 17.1% |
| EBITDA | -14,023,301 | -14,282,160 | 8.62M |
| Free Cash Flow | — | — | 3.23M |
| Rev Growth | — | -9.5% | +15.3% |
| Debt/Equity | — | — | 0.19 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |